# Surface Transforms revenues grew 81% to £7.3m, £390m order book

- Link: https://www.directorstalkinterviews.com/surface-transforms-revenues-grew-81-to-7.3m-390m-order-book/4121162715
- Published: 2024-06-28T07:09:16+01:00
- Author: Amilia Stone

**[Surface Transforms](https://www.directorstalkinterviews.com/company/surface-transforms-plc/sce.l)
plc** ([LON:SCE](https://www.directorstalkinterviews.com/company/surface-transforms-plc/sce.l)),
manufacturers of carbon fibre reinforced ceramic automotive brake discs, has announced
its audited results for the twelve months ended 31 December 2023.

**Financial highlights**

·      Revenues grew 81% to £7.3m (2022 restated £4.0m), following change to revenue
recognition criteria

·      Gross margin 57% (2022 Restated: 64%), reduction due to higher temporary 
outsourcing

·      Net research costs of £9.7m (2022: £5.6m)

·      £9.2m non-cash impairment of tangible assets (£3.0m) and Intangible assets(
£6.2m)

·      Loss after taxation, including £9.2m impairment, was £19.6m (2022 Restated:
£5.3m)

·      Loss per share of 7.92p (2022 Restated: 2.58p)

·      Cash used in operating activities £10.3m (2022: £6.5m)

·      Cash at 31 December 2023 of £6.1m (2022: £14.9m)

·     £10.1m equity placing and open offer to support ongoing working capital needs
in the year and £8.8m net of fees further equity raised post balance sheet

·      £13.2m loan secured to fund future capital investment

**Customer highlights**

·      Increased order book by £100m (lifetime value) to £390m at the end of the
year

·      Further demonstrated the ability to win “carry over” business with existing
customer OEM 10

·      5 contracts in multi-year revenue generation phase

·      Customers have been critical but supportive in response to our production
difficulties

**Operational highlights**

·      Continuing operational problems restricted sales throughout the year albeit
quarter- on – quarter growth in output

·      Resultant extensive program of technical, personnel and process changes in
the year to reduce equipment down time and scrap rates

·      Capital investments of £9.1m (2022: £8.4m) in the year

·      Capacity constraints progressively reduced

·      Focus now on improving process capability of all operations

**Senior Management Changes**

·      Post balance sheet, in April 2024, David Bundred announced his intention 
to retire as Chairman

·      Isabelle Maddock joined the board as CFO on 4 September 2023

·      Stephen Easton appointed COO on 4 September 2023

·      Michael Cunningham resigned from the Board as CFO on 31 May 2023

**Other**

·      Awarded London Stock Exchange “Green Economy Mark” in the year

**Posting of Annual Report and Notice of Annual General Meeting:**

The Company’s Annual Report and Accounts for the year ended 31 December 2023, together
with a notice convening the Company’s Annual General Meeting (“AGM”) will be posted
to shareholders today and will be available on the Company’s website [www.surfacetransforms.com](http://www.surfacetransforms.com/).

The AGM will be held at 1 Paternoster Square, London, EC4M 7DX on 23 July 2024 at
11.00 a.m.

**Chairman’s Statement**

After many years of product development, leading to our £390m order book, 2023 was
dominated by the challenge of converting that hard won order book into consistent
volume production. Progress was made, sales have grown in each quarter, we were 
awarded a significant carry over contract in the year, but the overall operational
progress simply was not good enough.

As a result, the Company had to seek fresh equity funding both in 2023 and in May
2024, and in parallel negotiated a £13.2m loan ringfenced for capital expenditure.
The pricing of the funding and resultant market capitalisation has impacted the 
annual review of asset valuation and led to a subsequent, non-cash, asset impairment.
The Board obviously regrets the circumstances that have led to these distressed 
equity raisings and completely understands the frustration and anger of shareholders
over the subsequent dilution. The Board believes the combination of these equity
fundraisings and local authority loan is sufficient for working capital and capital
expenditure needs.

**Sales Progress**

The Company is growing; 81% year on year revenue growth. The central issue in 2023
was that there was sufficient demand for twice the level of the H2 output; we had
originally forecast that we would satisfy this demand, but production issues meant
we could not.

**Progress on Operations**

Surface Transforms is not sales constrained. The inability to achieve production
targets, a recurring theme of 2023, has therefore been a continuing key frustration.
We are in a learning curve, involving numerous interrelated but separate technical
problems. That learning curve has proved to be both steeper and longer than we expected.

There were three broad reasons for these continuing 2023 problems, the delays in
installing notional capacity, the inability to achieve the target output from this
notional capacity and the personnel learning curve.

·      **New capacity installation delays:** the Company entered 2023 without adequate
capacity to meet demand and spent the year closing the capacity gap with £5.8m of
fixed asset capital expenditure in the year.

The background is well known to shareholders. We ordered our Phase 1 £20m p.a. sales
capacity in 2020, and phase 2 (£50m p.a.) in 2021. For both phases, we believed 
that 2 years was sufficient lead time for both the suppliers and the Company. Additionally,
we assumed, that the projected demand for 2023 would not exceed £20m.

In the event the plant has taken 3 years, not 2, to build and commission, and the
speed of our commercial success exceeded our most optimistic assumptions. The subsequent
lack of capacity impacts the Company in two ways. Firstly, we had underlying demand
for £30m sales in 2023, that we could not satisfy, requiring careful customer management.
However, the immediate 2023 problem was that without the headroom of spare capacity,
a single point of failure (down time or scrap) on a single machine became a total
factory bottleneck.

The Phase 2 £50m sales capacity was progressively installed during the year and 
into 2024. With one exception, the £50m notional capacity has been achieved in the
first half of 2024, albeit with work required on process capability to achieve all
the notional capacity. The outstanding item from this £50m programme is one furnace
that is now expected to be installed at the end of the year.

However the growth in demand continues and the installed capacity increase will 
soon be thereafter be overtaken by the next step change in demand, requiring the
next part of the phase 2 capacity increase to £75m. This increase to £75m sales 
is planned for commissioning in H2 2025, with equipment being ordered in 2024. That
task is underway and is in line with plan.

In summary we had planned to take 2 years to install our £50m capacity but will 
have taken over 3 years. The 2024 capacity task is therefore twofold; completing
this phase to £50m p.a capacity increase whilst, at the same time, ordering the 
plant for our £75m p.a sales factory, thus competing Phase 2. We expect to have 
balanced short-term demand and capacity by the end of 2024 and will maintain this
resilience thereafter.

·      **Process capability, and scrap:** the issue of lack of capacity was compounded
by the inability, in some sub processes to achieve the planned output from this 
notional capacity. As the Company scaled production, technical (and some tooling)
issues emerged with the capital equipment that were not apparent during the development
phase resulting in excessive down time and scrap. Running furnaces 24/7 is a different
challenge to running them occasionally producing prototype volumes.

The central problem was excessive variability in some production processes – known
as process capability. The effect was high levels of rejected product scrap. Improving
process capability is a well-known technique in volume manufacture, requiring detailed
analysis of input and output variables. This programme started in the year with,
reduced scrap results already seen in 2024.

·      **New personnel and procedures:** we always knew that setting up a volume
production site required new skills and operational procedures not previously needed
in a prototype factory. Not everybody in our original team, at all levels, was able
to transition from prototype to volume production.

To this end the Company made two significant senior management appointments in Q3
2023, with Isabelle Maddock joining us as Chief Financial Officer and Stephen Easton
as Chief Operating Officer. In turn, both Isabelle and Stephen have subsequently
made further appointments in their own departments. In particular, over the last
few months, operations have been significantly re-organised, at all levels, involving
both new and existing personnel, with, for example a fundamentally different approach
to the type of furnace technicians and maintenance personnel we needed.

We have also instigated a step change in internal training, ranging from CNC programming
for operators to a Manchester University executive degree programme for managers.
We have always been proud of being a “learning” company, (27% of our workforce are
graduate level) but nonetheless have now stepped up a gear in that area.

In parallel, the Company has undertaken a deep review of the organisational procedures
of operational planning, maintenance, quality, and supplier development. Unsurprisingly
all show the potential for significant improvement with work on these projects, 
under the new leadership, now well advanced.

**Progress with customers**

Given the operational background the key commercial task in 2023 was to ensure that
we kept customers fully informed, including realistic expectations of what they 
could expect. The customer’s response has been what we would have hoped; they have
reiterated that they want to buy our product and expect us to fix our operational
problems. They have been, rightly, critical but have also offered technical support.
We remain in continuous dialogue.

Crucially, the customers continue to support us. Indeed OEM 10 awarded us a carry-
over £100m contract in October 2023. We do not take this support for granted and
whilst the threat to existing contracts now seems under control, the real proof 
of our ongoing relationship will be the continuing ability to convert the prospective
contract pipeline (“PCP”) into firm orders. Customers will want to see firm operational
progress before making future commitments.

Looking beyond 2024 we have contracted demand that enables us to reach up to £75m
sales per annum within the next 4 – 5 years. Our PCP is in addition to this and 
is dominated by carryover business from our existing customers, and the Company’s
ambition remains generating revenues of £100m per annum within the next 5 years.

Beyond these major customers, we are continuing to widen our customer base including
the very small niche vehicle builders (we describe them as “Near OEMs”) as they 
provide both a very attractive return on the investment required, offer a degree
of flexibility in our operational planning and have only a marginal impact on capacity
in a market segment that is growing and larger than we previously believed.

**Trading Update and Outlook**

The Board’s expectation of 2024 and 2025 financial performance are unchanged from
those described in the recent fund raising, albeit now at the lower end of that 
described range. And as we note in our going concern statement below, at the current
time we need to recognise a material uncertainty in our sales forecast. As described
in the fundraising circular dated 3 May 2024, the first half of 2024 is expected
to be one of consolidation as capacity is installed and the process capability work
maintains momentum, with growth accelerating in the second half. Almost all the 
single point of failure capacity bottlenecks have now been dealt with.

In relation to which, significant progress was made in Q1 on reducing scrap and 
expanding capacity; this continued into Q2. However, April and May were impacted
by operational supply chains caused by our working capital constraints in Q2 (now,
since early June, fully resolved by the fund raising). The Company will be reporting
the output for H1 FY24 before the Annual General Meeting on 23 July.

To reiterate the comments above, the problematic furnace , the cost of which has
been fully impaired has neither had nor is expected to have an impact on overall
production output and the team has a longer term solution that avoids the need for
this furnace at all.

The Company’s ambition remains generating revenue of £100m sales per year within
the next five years.

**Summary**

The last twelve months have been, arguably, the most difficult in the history of
the Company. The operational underperformance was a particular disappointment leading
to the need for an unplanned cash injection. As previously stated, the Board obviously
regrets the circumstances that have led to this distressed fund raising and completely
understands the frustration and anger of shareholders over the subsequent dilution.

However, it is important to remind ourselves that the Company’s long-term sales 
and profit potential is unchanged. Our product works, is wanted by the marketplace,
there is still only one other worldwide competitor, the market is likely to be demand
constrained for at least the next 5 years, and we are continuing to install capacity
that will, eventually, reach £150m sales. The Board would not be building this capacity
without anticipating the detail of how we will fill it.

The central immediate need remains that of resolving the twin problems of installing
the capacity and then achieving the output from this notional capacity. Last year
we made progress yet there is still much work to be done, further progress has been
made in 2024 year to date and that continuing progress will be maintained.

Finally, I want to take the opportunity to thank employees for their valiant work
during a tough year and of course to thank all shareholders for their support of
our recent equity fundraisings.

**Financial Review**

**Prior Year Re-statement – Revenue Recognition for System Integration Services:**

We have reassessed our interpretation of revenue recognition for multi-year service
integration contracts under IFRS 15. This has resulted in changes to the criteria
upon which revenue is recognised for certain engineering, testing, and tooling services.
Previously, revenue had been recognised by a careful assessment of these services
over time based on the stage of completion for each contract, using detailed project
information. This approach which aimed to reflect a fair representation of revenue
earned, aligned with management’s previous interpretation of IFRS 15.

However, since we have been unable to adequately evidence the right to payment for
incomplete performance obligations, the criteria for recognising revenue has been
revised to only recognise revenue at a point in time being either upon completion
of system integration by the OEM or when control is passed over for the contracted
services.

**Impact of prior year:**

Based on this new interpretation management determined there to be a material difference
in how the Company has previously recognised revenue. To comply with IAS 8 the Company
is retrospectively applying this new interpretation and adjusting prior year audited
financial statements. The prior year revenue related to these services amounts to
a cumulative decrease of £1.4million, with £1.1m impacting 2022 and £0.3m impacting
2021.

These adjustments have also impacted other financial statement line items, such 
as cost of sales, contract receivables and contract fulfilment assets, as detailed
in Note 30. The Company now expects to recognise more revenue for these services
in future periods as system integrations are completed by the OEMs as detailed in
Note 3.

**Revenue**

Revenue increased 81% to £7.3m in 2023, driven by increasing customer in series 
production contracts.

Revenue expectations fell short notably stemming from the production challenges 
which took a considerable amount of research and development to overcome, impacting
timelines, revenue, overhead costs and cashflow. In response, the Company has made
a number of significant technical, personnel and procedural changes improving machinery
output, operational planning, maintenance, quality, and supplier development to 
enable a continuous evolution of the technology for more effective future scaling.

**Gross margin**

Gross profit margin decreased to 57% due to product mix and process outsourcing 
which will continue in 2024 whilst some of our larger pieces of equipment are installed
and commissioned.

**Overheads**

Administrative expenses rose 59% to £5.4 million in 2023, compared to £3.4 million
in 2022. In addition, £9.2m of impairments and £0.5m of other non- recurring costs
are discussed below.

Excluding the impairments and other non-recurring costs, underlying administrative
expenses increased by £2.0 million, primarily driven by the addition of 54 new personnel
to support series production. The Company was staffed to meet the forecast demand
that was not met due to the operational problems. Accordingly future growth, beyond
actual achieved 2023 revenues will not result in further proportional overhead increases.

Our commitment to research and development continues to fuel our growth, yet expenditure
in the year was unusually high rising, after capitalisation, by £4.0 million to 
£9.7 million (2022: £5.6m) during the period. The R&D spend was focussed on process
development, reflecting the considerable technical spend in the year fixing the 
manufacturing problems. This spend is reducing as the problems are being resolved.

Looking ahead, R&D expenditure is anticipated to stabilise at a more sustainable
level following the significant investments made in 2023. The valuable insights 
and improvements gained from this past year’s R&D efforts will inform future strategies.

Research will continue to focus on:

•              Exploring new techniques to enhance efficiency and product quality

•              Optimising production processes

•              Identifying ways to utilise better materials, and lower costs

This focus on continuous improvement through process and cost optimisation will 
remain a core strategy for the future.

**Other non-recurring costs**

As well as the unusually high incidence of R&D in 2023 management have identified
£0.5 million of non- recurring costs that were incurred in the first half of the
year due to a temporary lapse in our fixed-price energy contract. The Company has
secured fixed energy prices until March 2025, and the practice of fixed-term contracts
is expected to continue, management view this as an exceptional item albeit for 
reporting purposes it is within overhead.

**Impairment**

At the balance sheet date the Company recognised £9.2m of asset impairment.

As reported in the Chairman’s report we identified that a particular furnace is 
not performing to contracted specification. We have resolved the issue operationally,
using other furnaces and external supply but hold the supplier responsible for the
failure. We are pursuing potential contractual and legal remedies yet the outcome
remains uncertain. As a result of the furnace’s inoperability, an impairment of 
£3.0 million has been recognised in the Statement of Comprehensive Income for the
year. This figure reduces the value of the asset to the best estimate of its recoverable
amount. We have not recorded an asset in relation to any potential legal recovery
as we do not currently meet the recognition criteria for a contingent asset under
IAS 37.

IAS 36 requires us to assess the recoverable amount of our assets annually and whenever
there is an indication of impairment. To apply IAS 36 the Company has necessarily
included the recent fundraises as one market assessment indication along with the
risk inherent in the company. Management’s discounted cash flow model assumed no
expansion capital expenditure or growth beyond current capacity and applied a pre-
tax discount rate of 14% based on our determination of our weighted average cost
of capital. This initially demonstrated no impairment as the discounted cash flows
exceeded the carrying value of assets. In order to address the combined challenges
of cash flow forecasting risk in a scale up company and the potential gap between
implied market value and carrying value, we have reassessed the carrying value of
our assets. The final impairment test applied a pre-tax discount rate of 22% to 
reflect a further risk premium of 8%. This resulted in a recoverable amount lower
than the carrying value, and an impairment charge of £6.2 million, with £5.2 million
allocated to capitalised development costs and £1.0 million allocated to software
and right-of-use assets.

It’s important to note that the impaired development assets continue to generate
revenue aligned with our contracted order book with a lifetime value of £390 million.
As a consequence of this impairment, future amortisation expense related to these
assets will no longer be amortised on a systematic basis over each contract’s useful
life, thus reducing future amortisation expense.

A reconciliation of the above impairments is detailed in Note 4 to the accounting
statements.

**Exceptional costs**

The Company recognised £0.4m of other non- recurring exceptional costs in the year
relating to restructuring costs.

**Net loss**

Net loss in the year (after taxation) after impairments and other non-recurring 
and exceptional costs was £19.6m (2022 Restated: £5.3m). Expected tax credit similar
to previous years due to R&D tax regime. The increase in net loss was driven by 
significant levels of spend on research and development, production challenges and
high defects, growth in workforce in readiness for increased volumes and lower than
expected revenues.

**Cash Flow**

Gross cash at the year end was £6.1m (2022: £14.9m). Supported by £10.1m fundraising
to facilitate working capital growth, supplier and customer confidence.

**Balance Sheet**

Capital investment in the period amounted to £5.8m (2022: £8.4m), with an impairment
of £3.0m recognised against a furnace reflecting its best estimated recoverable 
amount. A further £6.2m impairment charge resulted in a £5.2 million reduction in
the carrying value of capitalised development costs and a £1.0 million reduction
in software and right-of-use assets. This impairment reflects the results of an 
impairment test using a pre-tax 22% discount rate.

Revenue grew in the period, leading to a £0.5 million increase in trade and other
receivables, a £0.6 million increase in contract fulfilment assets, and a £1.1 million
rise in inventory. Contract fulfilment assets are described in note 1 of the notes
to the financial statements.

**Equity**

During the year, Surface Transforms successfully raised £10.1 million in equity 
funding (net of fees) to support working capital requirements and fulfil orders.
Shareholder contributions, including the exercise of 1,120,000 employee share options,
totalled £10.5 million net of fees for the year. Despite this after the net loss
of £19.6m, net assets decreased by £9.1m.

**Loans**

In December 2023, the Company secured a £13.2 million loan from the LCR UDF Limited
partnership. This loan originates from Liverpool city region’s Urban Development
Fund, which is part-funded by the European Regional Development Fund (ERDF). The
loan will be used to invest in new manufacturing facilities, thereby increasing 
our production capacity. It is solely for capital purposes and can be drawn down
for eligible capital projects over the next 24 months until 31 December 2025. Similar
to a revolving credit facility, the loan liability will only be recognised once 
funds are drawn down. No funds had been drawn down as at 31 December 2023 accordingly
no financial asset or liability at 31 December 2023 has been recognised.

**Going Concern**

The continued operation of the Company as a going concern is dependent on our ability
to successfully navigate the upcoming scale-up phase. Two key areas of material 
uncertainty have been identified:

**1.   ** Scaling Up Production: Successfully ramping up production to meet the 
demands of our major OEM contracts is essential to our financial viability. This
process presents inherent risks, and any unforeseen challenges could delay our ability
to deliver on these contracts. Such delays could necessitate additional cash injections
to bridge any funding gaps.

**2.   ** Maintaining Financial Flexibility: Our current cash reserves provide us
with a runway to achieve our goals. However, there is a risk that we may exhaust
this cash headroom before achieving profitability. This scenario could lead to a
breach of our loan covenants, potentially jeopardising our access to future funding.

The Directors acknowledge the existence of a material uncertainty related to the
Company’s ability to continue as a going concern. This uncertainty arises from challenges
associated with yield improvement and necessary investments during the scale-up 
phase to meet production targets for the 12 OEM contracts. The duration and extent
of these challenges could significantly impact operational performance, particularly
sales and EBITDA generation, which are crucial for transitioning the Company from
a loss-making entity to a cash- generating business.

The Directors have modelled a management high case, base case and low case scenarios.
Performance since the balance sheet date has demonstrated strong growth on prior
year, yet short of management expectations for the base case forecast at the time
of writing this report.

Additional disclosures are given in note 1 to the financial statements to provide
an understanding of the forecast scenarios bank facilities, and cash. The Company
cannot be assured that it will not exhaust its cash headroom or breach its covenants
and that there is therefore a material uncertainty over the going concern of the
Company. The challenges are described in detail in this report along with mitigating
actions to address them.

Yield challenges have significantly impacted the Company’s profitability. Lower 
yields not only limit the number of saleable discs, reducing revenue, but also inflate
manufacturing costs due to disc scrappage before the final stage. This directly 
affects our profit margins.

Management has proactively addressed this issue. Recent months have seen several
successful upgrades to the manufacturing process, leading to a significant reduction
in scrappage rates. We are committed to long-term efficiency and scalability. While
strategically investing in process optimisation might temporarily delay reaching
desired production levels and impact cash flow in the short term, it will ultimately
establish a more robust and sustainable operation, well-positioned to meet future
demand.

Our ongoing investment to expand production capacity carries the potential for delays
or exceeding initial funding estimates. As our manufacturing strategy relies heavily
on capital and working capital expenditure, any unforeseen issues with existing 
equipment during production ramp- up, challenges with new equipment installation,
or delays in equipment investment or arrival could affect our ability to meet production
targets or limit our internally generated funding from operations.

To mitigate these risks, we leverage a dedicated Project Management Office (PMO)
with expertise in executing complex projects on time. The PMO proactively identifies
and manages long lead times for equipment within the program. Additionally, we prioritise
talent through proactive recruitment, retention, and development programs, including
graduate and apprenticeship initiatives under the guidance of seasoned PMO professionals.
These initiatives foster career progression, knowledge continuity, and succession
planning. While we are confident that our manufacturing plans incorporate sufficient
contingencies to fulfill existing, future, and prospective contracts, inherent uncertainties
could still impact our ability to achieve these goals within the anticipated timeframe.

Achieving our strategic goals hinges on effective planning, robust project management,
and access to timely management information. While we have growth plans in place,
executing them can put significant strain on our management, operational, financial,
and personnel resources.

Recognising this potential challenge, we are actively taking steps to mitigate it.
We are implementing a rigorous prioritisation framework within our phased approach
to growth. This ensures we focus on the most critical initiatives along the critical
path, ensuring efficient resource allocation. Additionally, we have proactively 
addressed resource constraints by:

·      Scaling our team: We have recruited experienced engineers and professionals
to bolster our technical expertise. We’re also investing in training and development
programs to upskill existing operators and create future team leaders.

·      Investing in technology: We view software applications supporting manufacturing,
maintenance, and project management as a continuous value-add process. Ongoing investment
in these tools streamlines operations and empowers our team.

Management believes the Company has the ability to meet future demand due to the
ongoing investments in capacity, people, software and process optimisation. However,
there can be no guarantee that recent improvements in yield can be maintained or
improved at levels in line with management expectations, particularly as production
volumes are increasing, and there can be no guarantee that the increase in production
capacity is effected at the pace planned for. For these reasons the Company cannot
be assured that it will not exhaust its cash headroom or breach its covenants, and
that there is therefore a material uncertainty over the going concern of the Company.

Notwithstanding the material uncertainty, after due consideration the Directors 
have a reasonable expectation that Surface Transforms has sufficient resources to
continue in operational existence for the period of 12 months from the date of approval
of these financial statements. Accordingly, the financial statements continue to
be prepared on the going concern basis. The circumstances noted above indicate the
existence of a material uncertainty which may cast significant doubt over the ability
of the Company to continue as a going concern. The financial statements do not contain
the adjustments that would arise if the Company were unable to continue as a going
concern.

Share on:
